Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dalmau

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
The Journal of Antimicrobial Chemotherapy|July 16, 2020
Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort studyBelén Alejos, Inés Suárez-García, Marta Rava, et al.
AIDS Reviews|March 18, 2009
HIV-1 genotypic drug resistance interpretation rules - 2009 Spanish guidelinesCarmen de Mendoza, Lourdes Anta, Federico García, et al.
Plos One|December 14, 2012
Monitoring HIV viral load in resource limited settings: still a matter of debate?Mireia Arnedo, Elena Alonso, Nell Eisenberg, et al.
Journal of Hepatology|June 20, 2012
All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infectionVictoria Hernando, Santiago Perez-Cachafeiro, Charlotte Lewden, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 27, 2005
Lack of association of SDF-1 3'A variant allele with long-term nonprogressive HIV-1 infection is extended beyond 16 yearsFrancesc Vidal, Joaquim Peraire, Pere Domingo, et al.
Medicina Clinica|June 13, 2013
[Cognitive complaints in people with human immunodeficiency virus in Spain: prevalence and related variables]José A Muñoz-Moreno, Maria J Fuster-Ruiz de Apodaca, Carmina R Fumaz, et al.
The Journal of Infection|October 29, 2017
Increased frequencies of Th17 cells and IL17a-producing regulatory T-cells preceding the immunodiscordant response to antiretroviral treatmentIsaac Rosado-Sánchez, Inés Herrero-Fernández, Laura Tarancon-Diez, et al.
Journal of Clinical Microbiology|September 6, 2003
Role of baseline human immunodeficiency virus genotype as a predictor of viral response to tenofovir in heavily pretreated patientsAna Barrios, Carmen de Mendoza, Luz Martín-Carbonero, et al.
Antiviral Therapy|February 2, 2012
Post-exposure prophylaxis for HIV infection: a clinical trial comparing lopinavir/ritonavir versus atazanavir each with zidovudine/lamivudineVicens Diaz-Brito, Agathe León, Hernando Knobel, et al.
Plos One|November 11, 2014
HIV-infection, atherosclerosis and the inflammatory pathway: candidate gene study in a Spanish HIV-infected populationLaura Ibáñez, Pablo Sebastián Velli, Roser Font, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
The Journal of Antimicrobial Chemotherapy|July 16, 2020
Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort studyBelén Alejos, Inés Suárez-García, Marta Rava, et al.
AIDS Reviews|March 18, 2009
HIV-1 genotypic drug resistance interpretation rules - 2009 Spanish guidelinesCarmen de Mendoza, Lourdes Anta, Federico García, et al.
Plos One|December 14, 2012
Monitoring HIV viral load in resource limited settings: still a matter of debate?Mireia Arnedo, Elena Alonso, Nell Eisenberg, et al.
Journal of Hepatology|June 20, 2012
All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infectionVictoria Hernando, Santiago Perez-Cachafeiro, Charlotte Lewden, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 27, 2005
Lack of association of SDF-1 3'A variant allele with long-term nonprogressive HIV-1 infection is extended beyond 16 yearsFrancesc Vidal, Joaquim Peraire, Pere Domingo, et al.
Medicina Clinica|June 13, 2013
[Cognitive complaints in people with human immunodeficiency virus in Spain: prevalence and related variables]José A Muñoz-Moreno, Maria J Fuster-Ruiz de Apodaca, Carmina R Fumaz, et al.
The Journal of Infection|October 29, 2017
Increased frequencies of Th17 cells and IL17a-producing regulatory T-cells preceding the immunodiscordant response to antiretroviral treatmentIsaac Rosado-Sánchez, Inés Herrero-Fernández, Laura Tarancon-Diez, et al.
Journal of Clinical Microbiology|September 6, 2003
Role of baseline human immunodeficiency virus genotype as a predictor of viral response to tenofovir in heavily pretreated patientsAna Barrios, Carmen de Mendoza, Luz Martín-Carbonero, et al.
Antiviral Therapy|February 2, 2012
Post-exposure prophylaxis for HIV infection: a clinical trial comparing lopinavir/ritonavir versus atazanavir each with zidovudine/lamivudineVicens Diaz-Brito, Agathe León, Hernando Knobel, et al.
Plos One|November 11, 2014
HIV-infection, atherosclerosis and the inflammatory pathway: candidate gene study in a Spanish HIV-infected populationLaura Ibáñez, Pablo Sebastián Velli, Roser Font, et al.
Pageof 8